Prevalence of SARS-Cov-2 antibodies and living conditions: the French national random population-based EPICOV cohort

被引：0
作者：
Josiane Warszawski
Anne-Lise Beaumont
Rémonie Seng
Xavier de Lamballerie
Delphine Rahib
Nathalie Lydié
Rémy Slama
Sylvain Durrleman
Philippe Raynaud
Patrick Sillard
François Beck
Laurence Meyer
Nathalie Bajos
机构：
[1] INSERM CESP U1018,AP
[2] Université Paris-Saclay,HP Epidemiology and Public Health Service
[3] AP-HP Epidemiology and Public Health Service,undefined
[4] Service,undefined
[5] Hôpitaux Universitaires Paris-Saclay,undefined
[6] Hôpitaux Universitaires Paris-Saclay,undefined
[7] Unité des Virus Emergents,undefined
[8] UVE,undefined
[9] Aix Marseille Univ,undefined
[10] INSERM 1207,undefined
[11] IRD 190,undefined
[12] Santé Publique France,undefined
[13] Inserm,undefined
[14] CNRS,undefined
[15] Team of Environmental Epidemiology applied to Reproduction and Respiratory Health,undefined
[16] Institute for Advanced Biosciences,undefined
[17] University Grenoble Alpes,undefined
[18] Institut thématique de Santé Publique,undefined
[19] INSERM,undefined
[20] DREES - Direction de la Recherche,undefined
[21] des Etudes,undefined
[22] de l’évaluation et des statistiques,undefined
[23] Institut National de la statistique et des études économiques,undefined
[24] IRIS,undefined
[25] INSERM,undefined
[26] EHESS,undefined
[27] CNRS,undefined
来源：
BMC Infectious Diseases | / 22卷
关键词：
COVID-19; SARS-COV-2; Seroprevalence; Population-based survey; Random sample; Risk factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 152 条
[1]  
Long Q-X(2020)Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections Nat Med 26 1200-1204
[2]  
Tang X-J(2020)Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: an up-to-date review Int J Infect Dis 101 314-322
[3]  
Shi Q-L(2020)Combating COVID-19: health equity matters Nat Med 26 458-458
[4]  
Li Q(2020)Factors associated with COVID-19-related death using OpenSAFELY Nature 584 430-436
[5]  
Deng H-J(2021)A national mixed-mode seroprevalence random population-based cohort on SARS-CoV-2 epidemic in France: the socio-epidemiological EpiCov study medRxiv 181 104880-544
[6]  
Yuan J(2020)Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors Antivir Res 396 535-1834
[7]  
Lai C-C(2020)Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study Lancet 12 905-319
[8]  
Wang J-H(2021)SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic Nat Commun 10 e041750-e12
[9]  
Hsueh P-R(2020)Evidence for ethnic inequalities in mortality related to COVID-19 infections: findings from an ecological analysis of England BMJ Open 26 1829-1656
[10]  
Wang Z(2020)Crowding and the shape of COVID-19 epidemics Nat Med 18 160-13
12345678910